TuHURA Biosciences, Inc. (HURA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$2.14+1.90%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · HURA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | FY 2013 | Jun 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 |
| Total Revenues | — | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 23.7 | 20.5 | 20.5 | 13.3 | 9.3 | 15.2 | 11.8 | 3.6 | 3.7 | (7.1) | 5.0 | 3.4 | 2.6 | 2.3 | 2.3 | — |
| Other Operating Expenses, Total | — | — | — | — | 0.1 | 0.0 | (0.0) | 0.1 | 0.1 | (0.0) | (0.0) | — | — | — | — | — |
| Operating Income | — | (30.1) | — | — | — | — | — | — | — | — | — | — | — | — | — | (0.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | 1.0 | 0.6 | 0.6 | 4.1 | — | — | 0.0 | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Other Non-Operating Income / Expenses | — | — | — | — | 0.1 | 0.0 | (0.1) | 0.1 | 0.4 | (0.0) | 0.2 | 2.7 | 0.4 | (2.0) | (2.0) | — |
| EBT, Incl. Unusual Items | — | (30.1) | (30.1) | 21.7 | — | — | — | — | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Net Income | (33.5) | (31.0) | (30.1) | (21.7) | (14.6) | (22.7) | (38.3) | (9.1) | (8.0) | 11.1 | (8.1) | 8.9 | (4.3) | (8.3) | (8.3) | (0.0) |
| Per Share | ||||||||||||||||
| Basic EPS | (0.52) | (0.63) | (0.63) | (1.21) | (9.27) | (25.80) | (1.60) | (0.87) | 3.16 | 5.42 | 7.36 | 0.83 | 0.46 | — | — | — |
| Diluted EPS | (0.52) | (0.63) | (0.63) | (1.21) | — | — | — | — | — | — | — | — | 0.11 | — | — | — |
| Basic Weighted Avg Shares | 64.0 | 47.9 | 47.9 | 18.7 | 1.6 | 1.0 | 25.9 | 10.4 | 2.6 | 2.1 | 1.2 | 10.9 | 9.5 | — | — | 3.1 |
| Diluted Weighted Avg Shares | 64.0 | 47.9 | 47.9 | 18.7 | — | — | — | — | — | — | — | — | 38.1 | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (30.0) | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBIT | — | (30.1) | — | — | — | — | — | — | — | — | — | — | — | — | — | (0.0) |
| Effective Tax Rate | — | -0.0% | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.